Scholars@Duke

CD5- B-cell lymphocytic leukemia -a diagnostic exclusion of splenic B-cell leukemia with prominent nuclei challenging current international consensus.

Journal articles  - Journal Article
Behman, J; Longobardi, S; Kang, G; Lingamurthy, M
Published in: Leuk Lymphoma
August 2025
Published version (DOI) Link to item

Duke Scholars

John Behman
Author John Behman Medicine, Hematologic Malignancies and Cellular Therapy
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leuk Lymphoma

DOI

10.1080/10428194.2025.2492608

EISSN

1029-2403

Publication Date

August 2025

Volume

66

Issue

8

Start / End Page

1550 / 1553

Location

United States

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Behman, J., Longobardi, S., Kang, G., & Lingamurthy, M. (2025). CD5- B-cell lymphocytic leukemia -a diagnostic exclusion of splenic B-cell leukemia with prominent nuclei challenging current international consensus. Leuk Lymphoma, 66(8), 1550–1553. https://doi.org/10.1080/10428194.2025.2492608
Behman, John, Stefan Longobardi, Grace Kang, and Manjesh Lingamurthy. “CD5- B-cell lymphocytic leukemia -a diagnostic exclusion of splenic B-cell leukemia with prominent nuclei challenging current international consensus.” Leuk Lymphoma 66, no. 8 (August 2025): 1550–53. https://doi.org/10.1080/10428194.2025.2492608.
Behman, John, et al. “CD5- B-cell lymphocytic leukemia -a diagnostic exclusion of splenic B-cell leukemia with prominent nuclei challenging current international consensus.” Leuk Lymphoma, vol. 66, no. 8, Aug. 2025, pp. 1550–53. Pubmed, doi:10.1080/10428194.2025.2492608.

Published In

Leuk Lymphoma

DOI

10.1080/10428194.2025.2492608

EISSN

1029-2403

Publication Date

August 2025

Volume

66

Issue

8

Start / End Page

1550 / 1553

Location

United States

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology